BN Agrochem reports a massive jump in consolidated revenue to Rs 873.28 crore for FY 2025-26, up from Rs 299.41 crore last year. The company is actively pursuing an amalgamation with three group entities, having secured BSE and CCI approvals. Shareholders will vote on substantial related party transactions and corporate guarantees during the upcoming AGM. While top-line growth is strong, investors should note the drop in EPS from 9.35 to 3.51 due to share structure changes and monitor the pending NCLT sanction for the merger.
BN Agrochem Reports Significant Revenue Growth and Merger Progress
BN Agrochem Ltd reported consolidated revenue of Rs 873.28 crore for FY 2025-26 compared to Rs 299.41 crore in the previous year. Profit After Tax rose to Rs 34.37 crore from Rs 19.76 crore in the same period.
Reader Takeaway: Strong revenue expansion signals scale, but watch for potential earnings dilution and future RPT governance standards.
What just happened
BN Agrochem has announced a strong financial performance for FY 2025-26 alongside a major corporate restructuring plan. The company is advancing a Scheme of Amalgamation with A1 Agri Global Limited, B.N. Agritech Limited, and Salasar Balaji Overseas Private Limited. The merger has cleared key regulatory hurdles, including NOCs from the BSE and the Competition Commission of India (CCI), with final sanction now pending from the NCLT.
Why this matters
The company is pivoting from a commodity-heavy model to a specialty-focused, consumer-oriented business. Management views the merger as an operating transformation designed to centralize procurement and optimize cash flow. Simultaneously, the company is diversifying its footprint with a Rs 72 crore investment in Epitome Industries India Limited to enter the downstream oleochemicals and specialty derivatives market.
Risks to watch
Investors should monitor the significant volume of proposed Related Party Transactions (RPTs), which could reach Rs 100 crore per transaction. Additionally, the drop in basic EPS from 9.35 to 3.51 indicates shifting share dilution dynamics that require attention. The ultimate success of the strategic roadmap remains contingent on final NCLT approval for the consolidation scheme.
What to track next
Shareholders will vote at the upcoming AGM on these RPTs and the decision to act as a corporate guarantor for a Rs 15 crore credit facility for B.N. Agritech Limited. Execution of the specialty products strategy will be the next major performance metric to watch.